# Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/informed-consent-recommendations-for-source-plasma-donors-participating-in-plasmapheresis-and-immunization-programs-guidance-for-industry/d7ebe62f-a512-4294-94c1-821faa558520

> FDA guidance document: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs:  Guidance for Industry. Issue date: June 01, 2007. Get complete insights and analysis.

---

## Details

- Title: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2007-06-01
- Last Changed: 2024-05-02
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2006-D-0350">FDA-2006-D-0350</a>

## Related Documents

- [Collection of Platelets by Automated Methods:  Guidance for Industry and FDA Review Staff](https://www.globalkeysolutions.net/guidances/guidance-document/collection-of-platelets-by-automated-methods-guidance-for-industry-and-fda-review-staff/3e3a4ad5-8406-4913-958f-aa82e587de6f)
- [Implementing a Collection Program for Source Plasma Containing Disease-Associated and Other Immunoglobulin (IgG) Antibodies:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/implementing-a-collection-program-for-source-plasma-containing-disease-associated-and-other-immunoglobulin-igg-antibodies-guidance-for-industry/4e8d104c-9a57-4ff5-99e6-5470b29e9cfa)
- [Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/safety-efficacy-and-pharmacokinetic-studies-to-support-marketing-of-immune-globulin-intravenous-human-as-replacement-therapy-for-primary-humoral-immunodeficiency-guidance-for-industry/fdf54353-36d9-4ac5-9115-08d310cb7de6)